Banka BioLoo Limited (BANKA) - Net Assets
Based on the latest financial reports, Banka BioLoo Limited (BANKA) has net assets worth Rs306.90 Million INR (≈ $3.32 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs801.17 Million ≈ $8.66 Million USD) and total liabilities (Rs494.26 Million ≈ $5.35 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Banka BioLoo Limited asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs306.90 Million |
| % of Total Assets | 38.31% |
| Annual Growth Rate | 38.17% |
| 5-Year Change | 5.19% |
| 10-Year Change | 1020.64% |
| Growth Volatility | 102.44 |
Banka BioLoo Limited - Net Assets Trend (2012–2024)
This chart illustrates how Banka BioLoo Limited's net assets have evolved over time, based on quarterly financial data. Also explore Banka BioLoo Limited assets under control for the complete picture of this company's asset base.
Annual Net Assets for Banka BioLoo Limited (2012–2024)
The table below shows the annual net assets of Banka BioLoo Limited from 2012 to 2024. For live valuation and market cap data, see Banka BioLoo Limited market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Rs315.85 Million ≈ $3.42 Million |
-20.56% |
| 2023-12-31 | Rs397.62 Million ≈ $4.30 Million |
-0.84% |
| 2022-12-31 | Rs400.99 Million ≈ $4.34 Million |
+6.92% |
| 2021-12-31 | Rs375.02 Million ≈ $4.06 Million |
+24.89% |
| 2020-12-31 | Rs300.28 Million ≈ $3.25 Million |
+7.13% |
| 2019-12-31 | Rs280.29 Million ≈ $3.03 Million |
+28.28% |
| 2018-12-31 | Rs218.50 Million ≈ $2.36 Million |
+22.47% |
| 2017-12-31 | Rs178.41 Million ≈ $1.93 Million |
+353.55% |
| 2016-12-31 | Rs39.34 Million ≈ $425.40K |
+39.56% |
| 2015-12-31 | Rs28.18 Million ≈ $304.81K |
+12.74% |
| 2014-12-31 | Rs25.00 Million ≈ $270.37K |
+190.09% |
| 2013-12-31 | Rs8.62 Million ≈ $93.20K |
+32.10% |
| 2012-12-31 | Rs6.52 Million ≈ $70.55K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Banka BioLoo Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 59196.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs114.44 Million | 36.32% |
| Common Stock | Rs108.74 Million | 34.51% |
| Other Comprehensive Income | Rs5.12 Million | 1.63% |
| Other Components | Rs86.83 Million | 27.55% |
| Total Equity | Rs315.13 Million | 100.00% |
Banka BioLoo Limited Competitors by Market Cap
The table below lists competitors of Banka BioLoo Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nagambie Resources Ltd
AU:NAG
|
$9.84 Million |
|
Fanhua Inc
F:4CIA
|
$9.84 Million |
|
Academies Australasia Group Ltd
AU:AKG
|
$9.85 Million |
|
Universal Security Instruments Inc
NYSE MKT:UUU
|
$9.85 Million |
|
Axolot Solutions Holding AB
ST:AXOLOT
|
$9.83 Million |
|
Orgenesis Inc
NASDAQ:ORGS
|
$9.83 Million |
|
AUX Resources Corporation
V:AUX
|
$9.82 Million |
|
Hammer Metals Limited
F:6HM
|
$9.82 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Banka BioLoo Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 397,199,000 to 315,134,000, a change of -82,065,000 (-20.7%).
- Net loss of 89,087,000 reduced equity.
- Share repurchases of 276,000 reduced equity.
- New share issuances of 276,000 increased equity.
- Other comprehensive income increased equity by 2,308,999.
- Other factors increased equity by 4,713,001.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs-89.09 Million | -28.27% |
| Share Repurchases | Rs276.00K | -0.09% |
| Share Issuances | Rs276.00K | +0.09% |
| Other Comprehensive Income | Rs2.31 Million | +0.73% |
| Other Changes | Rs4.71 Million | +1.5% |
| Total Change | Rs- | -20.66% |
Book Value vs Market Value Analysis
This analysis compares Banka BioLoo Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.88x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 131.83x to 2.88x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | Rs0.63 | Rs83.64 | x |
| 2013-12-31 | Rs0.84 | Rs83.64 | x |
| 2014-12-31 | Rs2.43 | Rs83.64 | x |
| 2015-12-31 | Rs2.74 | Rs83.64 | x |
| 2016-12-31 | Rs3.83 | Rs83.64 | x |
| 2017-12-31 | Rs22.83 | Rs83.64 | x |
| 2018-12-31 | Rs21.25 | Rs83.64 | x |
| 2019-12-31 | Rs27.26 | Rs83.64 | x |
| 2020-12-31 | Rs29.21 | Rs83.64 | x |
| 2021-12-31 | Rs36.45 | Rs83.64 | x |
| 2022-12-31 | Rs37.13 | Rs83.64 | x |
| 2023-12-31 | Rs36.78 | Rs83.64 | x |
| 2024-12-31 | Rs29.02 | Rs83.64 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Banka BioLoo Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -28.27%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -16.44%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 2.61x
- Recent ROE (-28.27%) is below the historical average (7.64%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 2.96% | 4.46% | 0.22x | 3.03x | Rs-459.30K |
| 2013 | 10.20% | 1.68% | 1.03x | 5.93x | Rs17.20K |
| 2014 | 3.02% | 0.92% | 1.41x | 2.32x | Rs-1.75 Million |
| 2015 | 11.30% | 2.23% | 1.49x | 3.40x | Rs366.50K |
| 2016 | 26.37% | 20.52% | 0.46x | 2.81x | Rs6.44 Million |
| 2017 | 10.60% | 11.44% | 0.70x | 1.33x | Rs1.07 Million |
| 2018 | 20.62% | 12.72% | 1.25x | 1.29x | Rs23.20 Million |
| 2019 | 22.22% | 13.01% | 1.02x | 1.67x | Rs34.24 Million |
| 2020 | 7.34% | 7.24% | 0.66x | 1.54x | Rs-7.98 Million |
| 2021 | 8.29% | 8.02% | 0.60x | 1.71x | Rs-6.43 Million |
| 2022 | 6.33% | 6.00% | 0.65x | 1.63x | Rs-14.71 Million |
| 2023 | -1.64% | -1.31% | 0.65x | 1.95x | Rs-46.24 Million |
| 2024 | -28.27% | -16.44% | 0.66x | 2.61x | Rs-120.60 Million |
Industry Comparison
This section compares Banka BioLoo Limited's net assets metrics with peer companies in the Pollution & Treatment Controls industry.
Industry Context
- Industry: Pollution & Treatment Controls
- Average net assets among peers: $1,444,197,607
- Average return on equity (ROE) among peers: 6.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Banka BioLoo Limited (BANKA) | Rs306.90 Million | 2.96% | 1.61x | $9.84 Million |
| ION Exchange (India) Limited (IONEXCHANG) | $1.44 Billion | 6.68% | 3.42x | $542.02 Million |
About Banka BioLoo Limited
Banka BioLoo Limited engages in the sanitation, fecal sludge, sewage, and wastewater treatment businesses in India. It is involved in the operation, setting up, and maintenance of fecal sludge, waste water, and effluent treatment plants. The company also offers BioToilet, BioDigester, and FootLoo; packaged sewage treatment plant; and sewage treatment plant, as well as operations and management se… Read more